
The expert guide to taking control of your emotions
Ever since he was a child, Ethan Kross has been "an observer of emotion" and the often counter-productive ways that we deal with difficult feelings. "It seemed as if we were all just stumbling along, occasionally finding an accidental or Band-Aid solution to help us manage our emotional lives. Sometimes our improvised tools helped. Sometimes they made things worse. It seemed so haphazard, isolating, and inefficient," he says.
As a psychologist at the University of Michigan and director of the Emotion and Self-Control Laboratory, Kross hopes to change this sorry state of affairs. In his new book Shift: How to Manage Your Emotions So They Don't Manage You, he aims to equip us all with a set of tools that will help us to navigate our ups and downs more constructively.
Kross spoke to science writer David Robson about the benefits of "negative" feelings, creating safe spaces and emotional oases – and the surprising upsides of distraction.
What are the most common misconceptions about emotions?
One big misunderstanding is that there are good emotions and there are bad emotions and that we should strive to live our lives free of all the bad emotions. This is an error, as far as I'm concerned: we evolved the ability to experience all emotions for a reason. Anger can motivate us to correct an injustice if there's still an opportunity to fix things. Sadness can lead us to introspect and make new meaning out of situations that have fundamentally been altered. Envy can motivate us to strive for things that we want to achieve. In the right proportions – that is such a key phrase – all emotions are useful.
One way of driving this point home is to think about physical pain, which is about as negative an emotional state as we can imagine. Many of us yearn to live lives free of any kind of physical pain. But some people are born without the capacity to experience pain, due to a genetic anomaly, and those kids end up dying younger than people who can experience pain. If they get their hand stuck in the fire, there's no signal that tells them to pull the hand away. The same principle is true for all our negative emotions.
People often find it liberating to know that they don't have to strive to live a life without negativity. What you want to strive to achieve is just keeping these emotional experiences in check, and I think that's a much more tenable goal.
Many people believe that their emotions are beyond their control. Where do you think this defeatist attitude comes from? And what are the consequences?
I think it depends on the facet of our emotional experiences that we're talking about. We often don't have control over the thoughts and feelings that are automatically triggered as we live our lives throughout the day, but we can control how we engage with those thoughts and feelings once they're activated, and that's where the promise of emotion regulation resides.
But if you don't think you can do something, then you're not going to make the effort to practice it. If you don't think exercising is going to make you more fit, for example, why on Earth would you devote effort to exercising? And if you don't think that you can use different strategies to manage your emotions, why would you ever avail yourself of them?
So how can we change our responses to difficult feelings?
Listening to music is one example of a tool that's underutilised. If you ask people why they listen to music, almost 100% of participants will say that they like the way it makes them feel. But if you then look at what people do when they are struggling with their emotions – such as the last time they were angry, anxious or sad – only a small minority report using music.
It's just one category of what I call "shifters", which are the tools that can push our emotions around. And once you know how they work, you can be a lot more strategic in how you use them in your life.
You also describe how a change in environment can boost our wellbeing. We might have experienced this on holiday, but how can we apply this principle to our day-to-day lives?
As you say, a lot of people feel restored when they go to an entirely different place that is free of associations with work. But we can't always take that vacation, and what I like to remind people is that there are often places locally that can shift our mood.
We talk a lot about getting attached to other people, and when things aren't going well, being in the presence of that figure can be a source of comfort and resilience. But it turns out we also become attached to places in our environment. Mine include the arboretum near my home, the tea house where I wrote my first book and one of my offices on campus. From the moment I am in that space, I have positive associations that help me manage my emotions.
I think that they're not unlike the safe houses you have in spy movies or books. We all have these safe houses in our lives, and we want to be strategic about going to them when we're struggling. It's a way of managing ourselves from the outside in.
You can also curate your environment. We know that plants and images of green spaces can be restorative. So can photos of loved ones. We've done research where we expose people to pictures of loved ones while they're struggling with a problem. We find it speeds up the rate at which they "repair" following the experience.
Is the aim to be more conscious of what we can do to change how we're feeling – rather than just leaving it to chance?
One of my hopes for this book is that we can get people to be much more deliberate about incorporating these tools into our lives.
I was surprised to find that distraction and avoidance can be a productive way of dealing with emotions. How so?
Avoidance – trying actively not to think about something by distracting yourself or engaging in other behaviours – is generally derided as an unhealthy tool. And there's no question that chronically avoiding things has been linked with negative outcomes; it's not an approach that I would advocate for anyone to adopt.
But we do not have to choose between either approaching or avoiding our emotions; we can be flexible and do both. There's research showing that people who are effective at both approaching and avoiding their emotions, expressing and suppressing, often fare well in the long term.
What might that look like in our lives? Well, let's say you're triggered by something. You get emotional about an argument you have had with someone. One approach might be to address it right there at that moment, but it might make sense to take some time away from thinking about that problem or confronting it. I say that as the kind of person who, in general, does like to confront things right in the moment, just get to the bottom of it, and move on. But sometimes I've benefited from immersing myself in something totally unrelated for a day and then coming back to the problem. I might come back and realise it's not a problem at all, or I'll find that the intensity of the problem is diminished, and I can approach it from a broader perspective.
How should we deal with that killer of joy, social comparison?
We often hear that we shouldn't compare ourselves to other people. Good luck! We're a social species; part of the way we make sense of ourselves and our place in this world is to compare ourselves to others.
It is true that we often engage in the kinds of comparisons that lead us to feel bad about ourselves, but you can reframe it in ways that make the comparison work for you rather than against you. If I find out that someone is outperforming me, I can say to myself, well, they were able to achieve that, so why can't I? Now it's almost like a target for something that I can shoot towards.
More like this:• Why we need to be more emotional to save the world• The untranslatable emotions you never knew you had• How climate change effects mental health
Do you have a favourite strategy that you would typically turn to in times of difficulty?
Oftentimes, those tools get me to where I want to be emotionally, but if they're not sufficient, I'll go to my emotional advisors, people in my network who are pretty skilled at empathising with me and advising me. And I'll go for a walk in a green space, or visit one of my emotional oases.
*Ethan Kross's new book Shift: Managing Your Emotions So They Don't Manage You is published by Vermilion (UK) and Crown (US).
** David Robson is an award-winning science writer and author. His latest book, The Laws of Connection: 13 Social Strategies That Will Transform Your Life, was published by Canongate (UK) and Pegasus Books (US & Canada) in June 2024. He is @davidarobson on Instagram and Threads and writes the 60-Second Psychology newsletter on Substack.
--

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Scottish Sun
5 days ago
- Scottish Sun
New link between ‘King Kong' of fat jabs and breast cancer, discovered – are you affected?
Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) IT seems every week there's a new claim about what fat jabs can cure - beyond banishing that belly. The so-called skinny jabs - that were initially designed as treatment for type 2 diabetes, could lower the risk of breast cancer. Sign up for Scottish Sun newsletter Sign up 3 Mounjaro has been dubbed the 'King Kong' of fat jabs for its powerful weight-loss effects Credit: Getty 3 Scientists are exploring how this jab could help prevent cancer Credit: Getty Since exploding onto the weight loss scene, GLP-1 drugs have been found to come with extra beneficial side effects, according to various studies. They range from lowering the risk of heart disease, dementia, lung disease, depression as well as increasing libido and helping to combat addiction to booze and drugs. And now, scientists in the US have found another pro to the seemingly "miracle" drugs, specifially tirzepatide, the ingredient behind Mounjaro, may "significantly" slow the growth of breast cancer tumour. That said, the experiments were conducted on mice and so the experts cautioned further research was necessary to confirm their findings. The authors from the University of Michigan also didn't speculate on why the drug, nicknamed the 'King Kong' of all fat jabs for its effectiveness, might lower a patient's risk of cancer It comes as breakthrough research in May revealed that GLP-1s could help ward off up to dozens types of cancer, including breast. "While these are very preliminary results, they suggest that this new anti-obesity drug may also have a beneficial impact on breast cancer outcomes," study author, Amanda Kucinskas, said. For the study, researchers tracked 16 obese mice with breast cancer tumors, which were made obese by feeding them a high-fat diet starting at nine weeks old. When the mice reached 32 weeks, middle age for a mouse, they were split into two groups. One group received tirzepatide injections every other day for 16 weeks, while the other was given a placebo. Weight Loss Jabs - Pros vs Cons Throughout the treatment, the team monitored the mice's weight and tumor size twice weekly. Those treated with tirzepatide lost about 20 per cent of their body weight, mirroring weight loss seen in humans taking the drug Mounjaro over long periods. Additionally, these mice developed noticeably smaller tumors. The study highlighted a strong connection between reduced body weight and smaller tumors, with fat mass playing a key role in tumor growth. Most of the fat loss came from the body's main fat stores, which is called adipose tissue. What are the signs of breast cancer? BREAST cancer is the most common type of cancer in the UK. The majority of women who get it are over 50, but younger women and, in rare cases, men can also get breast cancer. If it's treated early enough, breast cancer can be prevented from spreading to other parts of the body. Breast cancer can have a number of symptoms, but the first noticeable symptom is usually a lump or area of thickened breast tissue. Most breast lumps aren't cancerous, but it's always best to have them checked by your doctor. You should also speak to your GP if you notice any of the following: a change in the size or shape of one or both breasts discharge from either of your nipples (which may be streaked with blood) a lump or swelling in either of your armpits dimpling on the skin of your breasts a rash on or around your nipple a change in the appearance of your nipple, such as becoming sunken into your breast Source: NHS These findings were unveiled this week at ENDO 2025, the Endocrine Society's annual conference held in San Francisco. This research supports earlier findings shared at the American Society for Clinical Oncology (ASCO) conference in May, which suggested GLP-1 drugs might reduce the risk of 14 obesity-related cancers, including breast cancer, in diabetic patients. In that study, US researchers found that patients taking GLP-1 therapies had a 7 per cent lower chance of developing obesity-related cancers compared to those on DPP-4 inhibitors. When accounting for overall health benefits, the GLP-1 group was also 8 per cent less likely to die over a decade. 3


The Sun
5 days ago
- The Sun
New link between ‘King Kong' of fat jabs and breast cancer, discovered – are you affected?
IT seems every week there's a new claim about what fat jabs can cure - beyond banishing that belly. The so-called skinny jabs - that were initially designed as treatment for type 2 diabetes, could lower the risk of breast cancer. 3 Since exploding onto the weight loss scene, GLP-1 drugs have been found to come with extra beneficial side effects, according to various studies. They range from lowering the risk of heart disease, dementia, lung disease, depression as well as increasing libido and helping to combat addiction to booze and drugs. And now, scientists in the US have found another pro to the seemingly "miracle" drugs, specifially tirzepatide, the ingredient behind Mounjaro, may "significantly" slow the growth of breast cancer tumour. That said, the experiments were conducted on mice and so the experts cautioned further research was necessary to confirm their findings. The authors from the University of Michigan also didn't speculate on why the drug, nicknamed the 'King Kong' of all fat jabs for its effectiveness, might lower a patient's risk of cancer It comes as breakthrough research in May revealed that GLP-1s could help ward off up to dozens types of cancer, including breast. "While these are very preliminary results, they suggest that this new anti-obesity drug may also have a beneficial impact on breast cancer outcomes," study author, Amanda Kucinskas, said. For the study, researchers tracked 16 obese mice with breast cancer tumors, which were made obese by feeding them a high-fat diet starting at nine weeks old. When the mice reached 32 weeks, middle age for a mouse, they were split into two groups. One group received tirzepatide injections every other day for 16 weeks, while the other was given a placebo. Weight Loss Jabs - Pros vs Cons Throughout the treatment, the team monitored the mice's weight and tumor size twice weekly. Those treated with tirzepatide lost about 20 per cent of their body weight, mirroring weight loss seen in humans taking the drug Mounjaro over long periods. Additionally, these mice developed noticeably smaller tumors. The study highlighted a strong connection between reduced body weight and smaller tumors, with fat mass playing a key role in tumor growth. Most of the fat loss came from the body's main fat stores, which is called adipose tissue. What are the signs of breast cancer? BREAST cancer is the most common type of cancer in the UK. The majority of women who get it are over 50, but younger women and, in rare cases, men can also get breast cancer. If it's treated early enough, breast cancer can be prevented from spreading to other parts of the body. Breast cancer can have a number of symptoms, but the first noticeable symptom is usually a lump or area of thickened breast tissue. Most breast lumps aren't cancerous, but it's always best to have them checked by your doctor. You should also speak to your GP if you notice any of the following: a change in the size or shape of one or both breasts discharge from either of your nipples (which may be streaked with blood) a lump or swelling in either of your armpits dimpling on the skin of your breasts a rash on or around your nipple a change in the appearance of your nipple, such as becoming sunken into your breast Source: NHS These findings were unveiled this week at ENDO 2025, the Endocrine Society's annual conference held in San Francisco. This research supports earlier findings shared at the American Society for Clinical Oncology (ASCO) conference in May, which suggested GLP-1 drugs might reduce the risk of 14 obesity-related cancers, including breast cancer, in diabetic patients. In that study, US researchers found that patients taking GLP-1 therapies had a 7 per cent lower chance of developing obesity-related cancers compared to those on DPP-4 inhibitors. When accounting for overall health benefits, the GLP-1 group was also 8 per cent less likely to die over a decade. 3 Step-by-step guide on how to check boobs thoroughly Stand in front of a mirror with your hands by your sides, then above your head and place your hands on your hips and push in on your hips slightly. In each position, look for any changes in breast size or shape, and any new asymmetry, lumps or changes in outline. Look to see if your nipple is pointing in a different direction or has turned inwards (if you have always had inverted nipples, this is normal for you and not of concern). Check if there is any nipple discharge or crusting, any rashes, darker or red patches, or other changes such as the appearance of cellulite or if the skin is like orange peel. Feel the whole of the chest area with your finger pads, including the breast tissue that extends up to the collarbone and into the armpit. You are feeling for changes such as a lump, thickening or bumpy area. It does not matter exactly how you examine your breasts, be it in sections like a quarter at a time, or starting from the nipple and working outwards in circular motions, just that you examine the whole area. If you do notice any changes, see your GP.


Daily Mail
6 days ago
- Daily Mail
Scientists discover new link between Mounjaro and BREAST cancer
Mounjaro could help slash the risk of breast cancer tumours developing, exciting new research has suggested. The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health benefits, such as reducing the risk of heart attacks, strokes and kidney disease. Now, scientists have discovered that tirzepatide—the ingredient behind Mounjaro—may 'significantly' slow the growth of breast cancer tumours. American scientists, who carried out the trial, said the findings on mice show the drugs have a 'beneficial impact' on women with the disease. However, they cautioned further research was necessary to confirm their findings. Researchers also didn't speculate why the drug, which belong to class of medications called GLP-1 agonists, might lower a patient's chances of cancer. It comes as breakthrough research in May revealed that GLP-1s could help ward off up to 14 types of cancer including breast. Studies have also suggested obesity is a major risk factor in breast cancer returning and weight loss could improve outcomes. The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health benefits, such as slashing the risk of heart attacks, strokes and kidney disease Amanda Kucinskas, a research fellow in obesity and breast cancer risk at the University of Michigan and study author, said: 'While it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes. 'While these are very preliminary results, they suggest that this new anti-obesity drug may also have a beneficial impact on breast cancer outcomes,' In the study, researchers tracked 16 nine-week-old mice with breast cancer tumours who were fed a high-fat diet to induce obesity. At 32 weeks old—roughly middle age for a mouse—the obese animals were divided into two groups. One group received tirzepatide injections every other day for 16 weeks, and the other a placebo. Scientists then measured the mice's weight and tumour growth twice a week. They found mice on the medication lost around a fifth of their body weight—roughly the average weight lost by patients taking Mounjaro long term. The fat loss occurred mainly in adipose tissue, the body's fat-storing cells. Mice treated with tirzepatide also had significantly smaller tumors, the scientists said. There was a 'clear link' between lower body weight and smaller tumor size, while total fat mass was also 'strongly linked' to how large the tumors became, they added. However, they cautioned that exactly how tirzepatide slowed tumour growth was not yet understood and further tests, including in humans, would first be necessary. The findings were presented in full this week at ENDO 2025, the Endocrine Society's annual meeting in San Francisco. It comes as research presented at the American Society for Clinical Oncology (ASCO) annual conference in May suggested GLP-1s could slash the risk of 14 obesity-related cancer—including breast—for people with diabetes. US scientists found those on GLP-1s had a 7 per cent lower risk of developing an obesity-related cancer than patients on DDP-4 inhibitors, another diabetes medication. When other health benefits were factored in, these patients were also 8 per cent less likely to die over the 10-year period. In December, groundbreaking research presented at the San Antonio Breast Cancer Symposium also suggested the jabs could also help protect against breast cancer returning. One study of more than 1,000 patients by the University of Texas found obese patients who took the drugs for just over a year after finishing treatment on average had a 'significantly improved' chance of living longer. However, surprisingly, they also found patients taking hormone drugs such as tamoxifen—given to many women to stop breast cancer recurrence—gained weight, despite using the jabs. At the time, experts told MailOnline they were unsure why this happened. But they suggested it may be because hormone therapy typically causes patients to gain weight, meaning the jabs aren't able to work effectively. For these patients, 'we may need to go up to a higher dose', Professor Neil Iyengar, then an oncologist at the Memorial Sloan Kettering Cancer Centre, New York, said.